Kei Higaki

ORCID: 0000-0001-5211-1608
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Mesenchymal stem cell research
  • HIV Research and Treatment
  • Erythrocyte Function and Pathophysiology
  • RNA Interference and Gene Delivery
  • Hematological disorders and diagnostics
  • interferon and immune responses

Osaka University
2021-2022

Osaka International University
2021

Ube Frontier University
2021

Kyoto University
2018

Summary A population of mesenchymal stem cells, termed CXC chemokine ligand (CXCL)12‐abundant reticular (CAR) cells or leptin receptor‐expressing are the major cellular component niches for haematopoietic (HSCs) in murine bone marrow. CAR characterized by several salient features, including much higher expression CXCL12, cell factor (SCF), forkhead box C1 (FOXC1) and early B‐cell 3 (EBF3), which essential HSC maintenance, than other cells. However, human counterpart has not been fully...

10.1111/bjh.17396 article EN cc-by-nc British Journal of Haematology 2021-04-10

Abstract In bone marrow, special microenvironments, known as niches, are essential for the maintenance of hematopoietic stem cells (HSCs). A population mesenchymal cells, termed CXC chemokine ligand 12 (CXCL12)-abundant reticular (CAR) or leptin receptor-expressing major cellular component HSC niches. The molecular regulation niche properties is not fully understood. role Runx transcription factors, Runx1 and Runx2 in niches remains unclear. Here we show that predominantly expressed CAR mice...

10.1038/s41467-022-30266-y article EN cc-by Nature Communications 2022-05-12

Highly active antiretroviral therapy (HAART) has markedly prolonged the prognosis of HIV-1 patients. However, lifelong dependency on HAART is a continuing challenge, and an effective therapeutic much desired. Recently, introduction short hairpin RNA (shRNA) targeting promoter was found to suppress replication via transcriptional gene silencing (TGS). The technology expected be applied with hemato-lymphopoietic cell transplantation HIV patients transcription in transplanted cells. Combination...

10.1016/j.omtn.2018.07.017 article EN cc-by Molecular Therapy — Nucleic Acids 2018-08-04
Coming Soon ...